BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8033734)

  • 1. Tumor cell kinetics using two labels and flow cytometry.
    Ritter MA; Fowler JF; Kim YJ; Gilchrist KW; Morrissey LW; Kinsella TJ
    Cytometry; 1994 May; 16(1):49-58. PubMed ID: 8033734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
    Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
    Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry after bromodeoxyuridine labeling to measure S and G2+M phase durations plus doubling times in vitro and in vivo.
    Terry NH; White RA
    Nat Protoc; 2006; 1(2):859-69. PubMed ID: 17406318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.
    Begg AC; McNally NJ; Shrieve DC; Kärcher H
    Cytometry; 1985 Nov; 6(6):620-6. PubMed ID: 4064842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements.
    Perez LA; Dombkowski D; Efird J; Preffer F; Suit HD
    Cancer Res; 1995 Jan; 55(2):392-8. PubMed ID: 7812972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific staining of iododeoxyuridine and bromodeoxyuridine in tumors double labelled in vivo: a cell kinetic analysis.
    Pollack A; Terry NH; Wu CS; Wise BM; White RA; Meistrich ML
    Cytometry; 1995 May; 20(1):53-61. PubMed ID: 7541331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of sampling time on assessment of potential doubling time.
    Høyer M; Bentzen SM; Salling LN; Overgaard J
    Cytometry; 1994 Jun; 16(2):144-51. PubMed ID: 7924683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
    Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
    Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring potential doubling times of murine tumors using flow cytometry.
    Carlton JC; Terry NH; White RA
    Cytometry; 1991; 12(7):645-50. PubMed ID: 1782833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
    Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
    BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry.
    Begg AC; Hofland I
    Cytometry; 1991; 12(5):445-54. PubMed ID: 1718673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative method for evaluating bivariate flow cytometric data obtained using monoclonal antibodies to bromodeoxyuridine.
    White RA; Terry NH
    Cytometry; 1992; 13(5):490-5. PubMed ID: 1633728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous estimation of T(G2+M), T(S), and T(pot) using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry.
    White RA; Meistrich ML; Pollack A; Terry NH
    Cytometry; 2000 Sep; 41(1):1-8. PubMed ID: 10942890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flow cytometric analysis of cell proliferation kinetics using the anti-BrdUrd antibody].
    Sasaki K; Murakami T; Takahashi M
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2338-44. PubMed ID: 2751315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
    Hoshino T; Nagashima T; Murovic J; Levin EM; Levin VA; Rupp SM
    Cytometry; 1985 Nov; 6(6):627-32. PubMed ID: 2998714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
    Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
    Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell kinetics in mixed populations.
    Ritter MA; Albrechtson JL; Kim YJ; Kinsella TJ
    Cytometry; 1994 Jun; 16(2):118-28. PubMed ID: 7924680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous cell kinetics in tumors analyzed with a simulation model for bromodeoxyuridine single and multiple labeling.
    Baisch H; Otto U; Hatje U; Fack H
    Cytometry; 1995 Sep; 21(1):52-61. PubMed ID: 8529471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
    Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
    Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell kinetics of head and neck cancers.
    Kotelnikov VM; Coon JS IV; Haleem A; Taylor S IV; Hutchinson J; Panje W; Caldarelli DD; Griem K; Preisler HD
    Clin Cancer Res; 1995 May; 1(5):527-37. PubMed ID: 9816012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.